Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Rectal Neoplasms 6Esophageal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Head and Neck Neoplasms 5Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Pancreatic Neoplasms 3Lung Neoplasms 3Carcinoma, Squamous Cell 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Mouth Neoplasms 2Glioblastoma 2Carcinoma 2Adenocarcinoma 2Tonsillar Neoplasms 1Thrombocytopenia 1Resectable Esophageal Cancer 1Pharyngeal Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Neoplasms, Multiple Primary 1Neoplasms by Site 1Neoplasms 1Nasopharyngeal Neoplasms 1Melanoma 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Limited Stage Small Cell Lung Cancer 1Irritable Bowel Syndrome 1

Interventions

Cyclophosphamide 282Rituximab 260Etoposide 161Filgrastim 155Vincristine 145Doxorubicin 134Prednisone 117Cytarabine 108Radiotherapy 102Peripheral Blood Stem Cell Transplantation 90Methotrexate 90fludarabine phosphate 87Melphalan 78Busulfan 71Dexamethasone 59Granulocyte Colony-Stimulating Factor 56Carmustine 53fludarabine 51Bortezomib 46Tacrolimus 44Mycophenolic Acid 41Antilymphocyte Serum 41Ifosfamide 40Leucovorin 39Gemcitabine 38Whole-Body Irradiation 36Cyclosporine 35Bendamustine Hydrochloride 34sargramostim 33Methylprednisolone 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma × Chemoradiotherapy × Clear all
NCT01238159 2015-03-03

Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma

Samsung Medical Center

Phase 2 Completed
30 enrolled
Lymphoid

Lymphoma, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡